Skip to main content

Company News

  • July 23, 2025

    bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

    bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this collaboration is helping accelerate the development of individualized cancer treatments.
  • May 19, 2025

    bioMérieux Partners with First U.S. Hospital to Use VITEK® REVEAL™ Fast AST for Blood Stream Infections 

    bioMérieux is partnering with AdventHealth Orlando as they become the first institution to adopt the VITEK® REVEAL™ Fast Antimicrobial Susceptibility Testing (AST) System for clinical use in the United States.

  • April 17, 2025

    bioMérieux Embarks its Customers in a Circular Economy Initiative

    BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.
  • February 24, 2025

    bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases

    bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.
  • January 07, 2025

    bioMérieux, Tampa General Hospital and USF Health Host AMR Summit to Drive Action on Antimicrobial Resistance

    bioMérieux, Tampa General Hospital (TGH) and USF Health hosted the inaugural U.S. AMR Summit Nov. 12-13 to address the escalating global threat of antimicrobial resistance (AMR).

Follow us on Socials for more news!